previous compound ID: 2234 next compound
InChIKey: UNBRKDKAWYKMIV-QWQRMKEZSA-N
SMILES: CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "E Matthes" "DY Thomas" "B Kus" "J Liao" "D Rotin" "SD Macknight" "GW Carlile" "R Robert" "JW Hanrahan"

chemical graph of compound 2234





CID is 8226
synonyms found at PubChem are:
methylergonovine, Methylergometrine, Methylergobasin, Methylergometrin, Methylergobasine, Methylergobrevin, Methergine, Methylergonovin, Methergen, Partergin, Basofortina, Metilergometrina, Methylergometrinum, Methylergometrine maleate, 113-42-8, Methergin, Metilergometrinio, Metilergometrina [DCIT], Lysergic acid butanolamide, Ergometrine, methyl-, Methylergometrine [INN:BAN], Ryegonovin, Metenarin, Methylergometrinum [INN-Latin], Metilergometrinio [INN-Spanish], Spametrin-M, UNII-W53L6FE61V, ME 277, Ergotyl (TN), D-Lysergic acid-dl-hydroxybutylamide-2, D-Lysergic acid-(+)-butanolamide-(2), HSDB 3364, Methylergometrine (INN), N-(alpha-(Hydroxymethyl)propyl)-D-lysergamide, EINECS 204-027-0, W53L6FE61V, CHEMBL1201356, Lysergamide, N-((S)-1-(hydroxymethyl)propyl)-, 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-6-methylergoline-8-carboxamide, 9,10-Didehydro-N-(alpha-(hydroxymethyl)propyl)-6-methyl-ergoline-8-beta-carboxamide, Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(S))-, NCGC00017258-04, Methergine (TN), C20H25N3O2, DSSTox_CID_3283, DSSTox_RID_76957, DSSTox_GSID_23283, (8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide, Ergoline-8-beta-carboxamide, 9,10-didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methyl-, (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide, Ergotyl, CAS-113-42-8, Spectrum_000263, AC1L1QJP, Prestwick3_000374, Spectrum2_000613, Spectrum3_000502, Spectrum5_001879, Biomol-NT_000154, D05AHE, Lopac0_000794, SCHEMBL78176, BSPBio_000527, BSPBio_002023, GTPL150, KBioSS_000743, DivK1c_000357, SPBio_000546, D-lysergic acid 1-butanolamide, BPBio1_000442, BPBio1_000581, DTXSID1023283, CHEBI:92607, KBio1_000357, KBio2_000743, KBio2_003311, KBio2_005879, KBio3_001523, NINDS_000357, Tox21_110809, BDBM50330860, ZINC95619105, Tox21_110809_1, API0006820, CCG-204878, DB00353, IDI1_000357, NCGC00017258-03, NCGC00017258-05, NCGC00017258-06, NCGC00017258-08, NCGC00024646-02, NCGC00024646-03, LS-64363, SBI-0050771.P004, AB00514664, D08207, AB00053497_03, 191038-EP2275420A1, 191038-EP2280008A2, BRD-K34685430-001-01-1, BRD-K34685430-050-04-2, BRD-K34685430-050-06-7, (8beta)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-9,10-didehydroergoline-8-carboxamide, (4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide, 29477-86-9, 29589-73-9, 479-03-8, 78207-86-0, H8D